Is It Safe to Use Arterial Grafts in Patients with Acute Myocardial Infarction? Short-Mid-Term Propensity Analysis

Leonardo Lacava1, Gabrielle Barbosa Borgomoni2,3, Leticia de Mendonça Lopes1

  • 1Department of Cardiovascular Surgery, Hospital Regional São Paulo (HRSP), Xanxerê, Santa Catarina, Brazil.

Abstract

Insights

Using multiple arterial grafts (MAGs) for coronary artery bypass grafting (CABG) in acute myocardial infarction (AMI) shows no mid-term clinical disadvantage compared to single arterial grafts (SAGs). This finding supports the use of MAGs in AMI patients.

Area of Science:

  • Cardiovascular Surgery
  • Cardiac Surgery Outcomes
  • Myocardial Infarction Treatment

Background:

  • The optimal arterial graft strategy for acute myocardial infarction (AMI) patients undergoing coronary artery bypass grafting (CABG) remains debated.
  • Multiple arterial grafts (MAGs) may offer survival benefits, but their use in the acute phase of AMI requires further investigation.

Purpose of the Study:

  • To compare the short- to mid-term clinical outcomes of AMI patients treated with CABG using single arterial grafts (SAGs) versus MAGs.
  • To evaluate the safety and efficacy of MAGs in the acute setting of myocardial infarction.

Main Methods:

  • A cross-sectional cohort study of 4,053 patients from the REPLICCAR II registry.
  • Propensity score matching (PSM) was used to compare 35 patients receiving MAGs with a matched cohort receiving SAGs for AMI (n=238), with 70 patients evaluated post-PSM.
  • Clinical follow-up assessed readmission, new AMI, reoperation, and mortality.

Main Results:

  • Surgery duration was longer in the MAG group (median 4.78 hours) compared to the SAG group (median 4.11 hours) (P=0.040).
  • Bilateral internal thoracic artery was the most common MAG configuration (62.86%).
  • No significant differences in clinical outcomes were observed between MAG and SAG groups up to five years post-CABG.

Conclusions:

  • The use of MAGs in patients with AMI undergoing CABG was not associated with adverse clinical outcomes in the mid-term follow-up.
  • These findings suggest that MAGs are a safe and viable option for revascularization in AMI patients.